Stocktoria
10x Genomics, Inc. TXG
10x Genomics, Inc. financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $642.8M | $610.8M | $618.7M | $516.4M | $490.5M | $298.8M | $245.9M | $146.3M |
| Gross profit | $443.9M | $414.5M | $409.3M | $396.0M | $416.4M | $240.4M | $184.9M | $117.7M |
| SG&A expense | $316.1M | $344.3M | $343.3M | $298.3M | $257.6M | $202.3M | $130.8M | $87.9M |
| Operating income | -$61.0M | -$194.6M | -$265.3M | -$167.9M | -$52.3M | -$534.1M | -$30.6M | -$110.8M |
| Interest expense | — | — | $33,000 | $476,000 | $866,000 | $1.7M | $3.1M | $2.4M |
| Income tax | $3.6M | $4.9M | $6.3M | $4.0M | $4.5M | $8.3M | $218,000 | $87,000 |
| Net income | -$43.5M | -$182.6M | -$255.1M | -$166.0M | -$58.2M | -$542.7M | -$31.3M | -$112.5M |
| EPS (diluted) | $-0.35 | $-1.52 | $-2.18 | $-1.46 | $-0.53 | $-5.37 | $-0.80 | — |
| Operating cash flow | $136.1M | $6.7M | -$15.2M | -$33.6M | -$21.4M | -$217.9M | $34.6M | -$76.4M |
| Free cash flow | $130.1M | -$5.7M | -$63.8M | -$165.3M | -$122.7M | -$254.6M | -$8.1M | -$82.7M |
| Cash & equivalents | — | $344.1M | $359.3M | $219.7M | $587.4M | $663.6M | $424.2M | $65.1M |
| Inventory | $56.3M | $83.1M | $73.7M | $81.6M | $60.0M | $30.0M | $15.3M | $8.6M |
| Total assets | $1.0B | $918.6M | $965.1M | $1.0B | $1.0B | $929.3M | $605.9M | $124.3M |
| Total liabilities | $245.0M | $208.5M | $224.1M | $223.2M | $201.3M | $190.3M | $185.8M | $101.1M |
| Shareholders' equity | $796.3M | $710.1M | $741.0M | $805.7M | $817.6M | $739.1M | $420.1M | -$220.0M |
Growth · year-over-year · Revenue CAGR 23.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | +5.2% | -1.3% | +19.8% | +5.3% | +64.1% | +21.5% | +68.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.